Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intracardiac devices for stroke prevention.

Thuraia Nageh1, Bernhard Meier

  • 1Swiss Cardiovascular Center, Bern, Switzerland.

Preventive Cardiology
|January 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patent Foramen Ovale Closure in Stroke and the PASCAL Classification System.

JAMA neurology·2026
Same author

Percutaneous left atrial appendage closure with concomitant dual-device implantation: a single-center observational study.

Frontiers in cardiovascular medicine·2026
Same author

Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled Trial.

American journal of nephrology·2025
Same author

Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart Failure.

Journal of the American College of Cardiology·2024
Same author

A Cardiologist's Perspective on Patent Foramen Ovale-Associated Conditions.

Cardiology clinics·2024
Same author

Impact of gender in patients with device-related thrombosis after left atrial appendage closure - A sub-analysis from the multicenter EUROC-DRT-registry.

Echocardiography (Mount Kisco, N.Y.)·2024

Atrial fibrillation and patent foramen ovale increase stroke risk. Intracardiac devices offer alternatives for stroke prevention when anticoagulation is unsuitable.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • Stroke is a leading cause of death and disability globally.
  • Cardiac embolism, often from atrial fibrillation or patent foramen ovale, is a major stroke cause.
  • Oral anticoagulation is effective but has limitations, necessitating alternative stroke prevention strategies.

Purpose of the Study:

  • To review intracardiac devices and techniques for stroke prevention.
  • To discuss the role of left atrial appendage occlusion and patent foramen ovale closure.
  • To compare the merits of different interventional approaches for stroke risk reduction.

Main Methods:

  • Discussion of percutaneous left atrial appendage occlusive devices.
  • Review of surgical appendage obliteration techniques.

Related Experiment Videos

  • Analysis of percutaneous patent foramen ovale closure procedures.

    • Main Results:

    • Left atrial appendage occlusion and patent foramen ovale closure are emerging as viable options for stroke prevention.
    • Percutaneous closure of patent foramen ovale is safe and effective for preventing recurrent strokes.
    • These devices offer alternatives for patients unable to tolerate long-term oral anticoagulation.

    Conclusions:

    • Intracardiac devices provide important therapeutic options for stroke prevention.
    • Left atrial appendage occlusion and patent foramen ovale closure are key interventional strategies.
    • The choice of device and technique depends on individual patient factors and clinical context.